Management Team

Richard B. Hancock
Interim President and CEO and Director

Mr. Hancock has been a member of the Avid Bioservices Board of Directors since November 2017 and currently serves as the interim President and CEO. He has held a variety of executive positions in biotechnology for over thirty five years, most recently as President and CEO of Althea Technologies where he established its biologics and drug product contract manufacturing services and grew the business from inception to a recognized world leading CDMO with superior profitability and over 200 employees. He managed the acquisition of the company by Ajinomoto with an outstanding return on investment to shareholders. Mr. Hancock began his biotechnology career at Hybritech Inc., (subsequently Eli Lilly and Company) one of the earliest companies developing monoclonal antibodies for diagnostic and therapeutic applications. He held positions of increasing responsibility in Quality Control, Process Development and cGMP Manufacturing. Following Hybritech, he worked at Genetics Institute, (currently a division of Pfizer) in the development and commercialization of several first to market products including recombinant Factor VIII, Factor IX and Bone Morphogenetic Protein. At The Immune Response Corporation, a developer of novel vaccine candidates to treat HIV infection, Multiple Sclerosis, Rheumatoid Arthritis and other autoimmune diseases, he established the company’s Manufacturing, Process Development and Quality organizations and was responsible for production and release of all clinical materials from early stage development and scale-up to commercial readiness. Mr. Hancock currently serves as Executive Chairman of Argonaut Manufacturing Services, a CDMO producing a wide variety of medical devices, molecular diagnostics and parenteral drug products, and is a board member of Tempo Therapeutics. He received a BA in Microbiology from Miami University, Oxford, Ohio.

Daniel R. Hart
Chief Financial Officer

Daniel R. Hart has served as Chief Financial Officer since August 2018 and has over 20 years of finance and accounting experience.  Prior to joining Avid, Mr. Hart served as Chief Financial Officer of ENO Holdings, Inc., a family of companies focused on the residential real estate market with offerings spanning brokerage, franchisor, property management, and settlement services.  In this role, he helped improve the company’s organizational results with a focus on establishing repeatable financial and operating processes, cash forecasts, strategic planning, and financial transactions.  Prior to this role, Mr. Hart served as Senior Vice President, Chief Financial Officer and Assistant Secretary at SM&A, a $100 million private equity owned management consulting firm that was previously a Nasdaq-listed company.  During his ten years at SM&A, which included several financial leadership positions of increasing responsibility, he was responsible for overseeing financial stewardship and played a central role in various financial transactions and corporate acquisitions.  Mr. Hart also previously held positions with Biolase Technology, Inc., a Nasdaq-listed medical device manufacturer, FutureLink Corp. a Nasdaq-listed hosted application service provider, and Deloitte & Touche LLP.  Mr. Hart holds a Bachelor of Science degree in accounting from California Polytechnic State University, San Luis Obispo and is a Certified Public Accountant in the State of California (inactive).

Richard Richieri
Chief Operations Officer

Mr. Richieri has over 25 years of biopharmaceutical industry experience spanning the areas of drug discovery, CGMP operations, contract manufacturing and process development.  Mr. Richieri previously spent 15 years with Avid Bioservices and its former parent company, Peregrine Pharmaceuticals, including the role of senior vice president of manufacturing.  During that time, he was instrumental in launching, building and growing Avid’s CDMO business and helping the company diversify its production capabilities.  He spent the past five years serving as an advisor and acting head of biologics production for Syngene International, a global discovery, development and manufacturing organization serving the pharmaceutical industry.

During his career, Mr. Richieri has also served as a global advisor for Samsung Biologics’ biosimilar program as well as president of Bioserv Corporation, a specialized contract manufacturing organization.  He most recently served as co-founder of Rubicon Biotechnology, where he was responsible for process development and manufacturing of the company’s novel therapeutic candidates.  He earned a bachelor’s degree in chemical engineering from the University of California, Los Angeles (UCLA) and a master’s degree in chemical engineering from the University of California, San Diego (UCSD).

Mark Ziebell
Vice President, General Counsel and Corporate Secretary

Mark Ziebell has served as Vice President and General Counsel since June 2012. Prior to joining the organization, Mr. Ziebell was a Partner at Snell & Wilmer LLP, a law firm based in Orange County, California where his practice specialized in securities law, mergers and acquisitions, corporate governance and general corporate law representing companies in a broad range of industries including the biopharmaceutical and technology sectors. Prior to Snell & Wilmer he was a Partner at the law firm of Falk, Shaff & Ziebell where he was part of the Corporate and Securities practice area. Prior to that Mr. Ziebell has held positions of increasing responsibility within the accounting and legal sectors. Mr. Ziebell holds a JD degree from the University of San Francisco, School of Law and a BA in Accounting from the University of San Francisco.

Tracy L. Kinjerski
Vice President, Business Operations

Tracy Kinjerski has more than 17 years of experience in the biopharmaceutical industry and joined Avid as the Vice President of Business Operations in November 2017. She most recently served as senior director of global business development at CMC Biologics, a global CDMO. In that role, her efforts spearheading business development and client relationship management generated significant new business growth in less than one year of joining the company. Prior to CMC Biologics, Ms. Kinjerski spent nearly five years with Fujifilm Diosynth Biotechnologies, the global CDMO division for Fujifilm. During her tenure, she served as director of commercial development focused on the East Coast of the US, helping to grow the company’s clinical and commercial business through new client engagements spanning global pharmaceutical companies, biotechnology companies of all sizes and government projects. Ms. Kinjerski, who holds a master’s degree in biomedical sciences, has also served in business and commercial development leadership positions at Althea Technologies and Avecia Biologics Billingham (since acquired by Fujifilm Diosynth), two fully-integrated CDMOs serving the pharmaceutical and biotechnology industries.

Magnus Schroeder, Ph.D.
Vice President, Process Development

Dr. Schroeder joined Avid as the Vice President of Process Development in May 2018. He most recently served as a director at AGC Biologics, formerly CMC Biologics, a global contract development and manufacturing organization, where he participated in the successful commercial launch of multiple products.  In that role, he successfully supported more than 25 client projects as they progressed toward first-in-human clinical trials, commercial product launch and ongoing commercial supply.  These efforts included creative resolution of complex challenges related to commercial processes that directly impacted a range of regulatory interactions and filings.  In directing AGC’s purification development team, Dr. Schroeder oversaw early-to-late phase development, process characterization, process control strategy, commercial process support and technology transfer/facility fit activities.  Prior to AGC Biologics, Dr. Schroeder held multiple senior level positions with CSL Limited, a global leader in the field of biotechnology.  During his tenure, he served as senior manager and senior scientist, leading process development activities for a range of CSL’s innovative biologics.  He has also held key process science positions with Dynavax Technologies, in which he was responsible for supporting process development, characterization and validation for multiple programs.  Dr. Schroeder earned his Ph.D. in biochemical engineering and his master of science in molecular biotechnology from Bielefeld University in Bielefeld, Germany.  He has previously served as a visiting scientist for protein purification at Rensselaer Polytechnic Institute and a visiting scientist for cell culture engineering at the University of Minnesota.

Ray Marzouk
Vice President, Quality

Ray Marzouk leads the quality assurance operations for commercial products at Avid Bioservices. He also heads the environmental monitoring program and microbiological testing functions. Ray has over 20 years in the biopharmaceutical and pharmaceutical industry serving in managerial, technical, and quality engineering capacities in a cGMP environment. Prior to joining Avid in 2007, Ray was with B. Braun Medical Inc. for twelve years in various quality control roles. Ray earned his bachelor’s degree in microbiology and molecular genetics from the University of California, Los Angeles. He obtained certification as a specialist microbiologist with the National Registry of Certified Microbiologists (NRCM).

Nick Ferguson
Executive Director, Information Technology

Nick Ferguson leads the information technology, data governance, IT compliance, laboratory informatics, and validation groups at Avid Bioservices. Nick joined the organization in 1999 (under Techniclone Corporation) and has over 20 years of experience in the industry. Nick is responsible for all corporate and GxP systems. Nick is a goal-driven leader, known for his proven expertise in managing IT operations, inspirational leadership style, and delivering enterprise solutions to meet the needs of the business. In his free time, he is involved with multiple NGOs to build infrastructure in third world countries.

Lorna Larson
Senior Director, Human Resources

Lorna Larson leads the human resources group at Avid Bioservices and oversees organizational development, training and development, talent acquisition, compensation and benefits, and employee relations. In her past roles, she has developed and executed global, regional HR strategies across industries including pharmaceutical, medical device, financial services, and internet commerce. Her track record of building HR credibility and business specific solutions includes experience in the US, Europe, Latin America, and Asia Pacific. Her undergraduate degree is from the Business School at California State University at Long Beach, with an emphasis on Human Resources. She annually serves as a Corporate Mentor for CSULB. She holds a Master’s degree in Business from Pepperdine University. She has earned SPHR and CCP designations. In her free time, she is involved with the Sisterhood program for Human Options and a variety of other philanthropic activities.

Gene Yoshioka
Senior Director, Manufacturing

Gene Yoshioka heads operations at Avid Bioservices and oversees its cGMP manufacturing. Gene originally joined the organization in 1995 (under Techniclone Corporation) and has almost 20 years in the industry, with experience at Amgen in Thousand Oaks, Biogen Idec in San Diego, and Peregrine Pharmaceuticals in Tustin. Gene brings broad experience, including quality control, manufacturing, supply management, and process development; working with an extensive list of different molecules. When Avid was founded in 2002, Gene managed the production team, helping to establish Avid as a successful commercially licensed contract manufacturing organization. Gene earned his bachelor’s degree in biology at the University of California, Irvine.

Teresa Berry
Director, Engineering and Facilities

Teresa Berry heads the engineering and facilities departments at Avid Bioservices. With over 22 years of experience in the biopharmaceutical industry, she oversees the day-to-day facilities’ operations—from preventative maintenance and calibrations to construction projects. Teresa established robust cGMP programs for equipment and utility systems when she joined the organization in 2001, working for Avid’s parent company, Peregrine Pharmaceuticals, Inc. In 2002, Teresa played an integral role in launching and establishing Avid Bioservices as a successful contract manufacturing organization. Teresa holds a bachelor’s degree in health sciences from the California State University, Long Beach and is a member of the International Brotherhood of Electrical Workers, as a journeyman inside wireman. In addition, she is a long-standing member of the International Society for Pharmaceutical Engineering (ISPE). Teresa got her start in biotechnology with XOMA and Agensys, Inc. She also has more than 12 years’ experience in the construction industry, which enables her to serve Avid’s needs.